HPR25 Current Reimbursement Landscape for Re-Treatment with Anti-PD-(L)1 Agents after Treatment in Early-Stage Cancers: A Payer Survey
Abstract
Authors
R Aguiar-Ibáñez A Kaliasethi D Ferreira A Lauer C Spiteri S Kothari C Alleman J Mckendrick